Skip to main content

CL10 6 mg Pill - orange red capsule/oblong, 18mm

Pill with imprint CL10 6 mg is Orange / Red, Capsule/Oblong and has been identified as Rivastigmine Tartrate 6 mg. It is supplied by Macleods Pharmaceuticals Limited.

Rivastigmine is used in the treatment of Parkinson's Disease; Alzheimer's Disease and belongs to the drug class cholinesterase inhibitors. There is no proven risk in humans during pregnancy. Rivastigmine 6 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for CL10 6 mg

Rivastigmine tartrate 6 mg CL10 6 mg
Rivastigmine tartrate 6 mg CL10 6 mg

Rivastigmine Tartrate

CL10 6 mg
6 mg
Orange / Red
18.00 mm
Prescription only
Drug Class
Cholinesterase inhibitors
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Macleods Pharmaceuticals Limited
National Drug Code (NDC)
Inactive Ingredients
magnesium stearate, microcrystalline cellulose, silicon dioxide, gelatin, titanium dioxide, sodium lauryl sulfate, ferric oxide red, ferric oxide yellow, hypromelloses

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.